THOR MEDICAL ASA: årsregnskap 2025 vs 2024
Cash halved-plus, fresh owner capital
approved 2026-03-26; registry 2026-07-09; journal 2026 544641
Summary
What changed
Comparing Årsregnskap 2025 with 2024 for THOR MEDICAL ASA. Revenue 0 NOK → 839.0k NOK. Net result -40.59m NOK → -42.47m NOK. Equity 341.5k NOK → 475.9k NOK.
On the constructive side: revenue rose; equity strengthened; owners injected capital. Pressures included: operating result weakened; cash fell; current ratio dropped below 1×.
Also worth watching: sharp cash drawdown; book investments changed. All figures are taken from the published annual accounts for THOR MEDICAL ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 0 NOK to 839.0k NOK. Calculated
-
↑
Equity strengthened
Book equity 341.5k NOK → 475.9k NOK (equity ratio 93.8% → 93.8%). Calculated
-
↑
Owners injected capital
Paid-in equity rose 400.2k NOK → 577.1k NOK (+176.9k NOK). Reported fact
What deteriorated
-
↓
Operating result weakened
Operating result -41.95m NOK → -50.42m NOK. Calculated
-
↓
Cash fell
Bank deposits 122.56m NOK → 179.8k NOK (-99.9% YoY). Calculated
-
↓
Current ratio dropped below 1×
Current ratio 5.75× → 0.01× — short-term liabilities now exceed liquid/current assets on the published lines. Calculated
Things to notice
-
·
Sharp cash drawdown
Cash fell by more than 60% YoY (122.56m NOK → 179.8k NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation
-
·
Book investments changed
Investment / intangible book value 234.71m NOK → 235.5k NOK. Reported fact